VistaGen Announces Nasdaq Listing and Pricing of $10.0 Million Public Offering May 10, 2016 07:36PM
VistaGen Therapeutics (VSTA) Highlighted at Chardan Capital After Allergan Acquires Comp Naurex Jul 27, 2015 08:23AM
Chardan Capital Starts VistaGen Therapeutics (VSTA) at Buy; Positive on AV-101 as Antidepressant Sans Ketamine Side Effects Jun 18, 2015 08:39AM